Liufu Rong, Wang Chun-Yao, Weng Li, Du Bin
State Key Laboratory of Complex Severe and Rare Diseases, Medical ICU, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing 100730, China.
J Clin Med. 2023 Jan 29;12(3):1043. doi: 10.3390/jcm12031043.
Acute respiratory distress syndrome (ARDS) is a common life-threatening clinical syndrome which accounts for 10% of intensive care unit admissions. Since the Berlin definition was developed, the clinical diagnosis and therapy have changed dramatically by adding a minimum positive end-expiratory pressure (PEEP) to the assessment of hypoxemia compared to the American-European Consensus Conference (AECC) definition in 1994. High-flow nasal cannulas (HFNC) have become widely used as an effective respiratory support for hypoxemia to the extent that their use was proposed in the expansion of the ARDS criteria. However, there would be problems if the diagnosis of a specific disease or clinical syndrome occurred, based on therapeutic strategies.
急性呼吸窘迫综合征(ARDS)是一种常见的危及生命的临床综合征,占重症监护病房收治患者的10%。自柏林定义制定以来,与1994年的欧美共识会议(AECC)定义相比,通过在低氧血症评估中增加最小呼气末正压(PEEP),临床诊断和治疗发生了巨大变化。高流量鼻导管(HFNC)已被广泛用作低氧血症的有效呼吸支持,以至于在ARDS标准的扩展中提出了其使用方法。然而,如果基于治疗策略进行特定疾病或临床综合征的诊断,可能会出现问题。